Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease
NCT07197099 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-11-18
Summary
The goal of this observational study is to Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals, including evaluating clinical response rates and functional improvement.
Conditions
- Neurological Autoimmune Diseases
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2025-10-30
- Completion
- 2025-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies
NCT03864185 ·Status: COMPLETED ·Phase: PHASE2
-
Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome
NCT04550611 ·Status: UNKNOWN ·Phase: NA
-
IVIg for Demyelination in Diabetes Mellitus
NCT02372149 ·Status: UNKNOWN ·Phase: PHASE4
-
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT01017159 ·Status: COMPLETED ·Phase: PHASE2
-
CPI Combination Therapy for Autoimmune Encephalitis
NCT03542279 ·Status: COMPLETED ·Phase: NA
-
Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
NCT07273903 ·Status: RECRUITING
-
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
NCT07337785 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy
NCT05225675 ·Status: COMPLETED ·Phase: PHASE2
-
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP
NCT05562960 ·Status: RECRUITING ·Phase: NA
-
InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04529291 ·Status: WITHDRAWN ·Phase: NA
-
GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases
NCT07021209 ·Status: RECRUITING ·Phase: PHASE1
-
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07032662 ·Status: RECRUITING ·Phase: PHASE2
-
A Registered Cohort Study of Immune-Mediated Neuropathies
NCT04292834 ·Status: UNKNOWN
-
Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
NCT04175522 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders
NCT04064944 ·Status: UNKNOWN ·Phase: PHASE2
-
PK of Meropenem in Patients on Plasma Exchange
NCT05042271 ·Status: UNKNOWN
-
A Phase I Clinical Trial of Meplazumab in Healthy Volunteer
NCT04369586 ·Status: COMPLETED ·Phase: PHASE1
-
IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases
NCT04687332 ·Status: COMPLETED ·Phase: NA
-
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
NCT04540497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
NCT06742190 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
NCT00004645 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT04881682 ·Status: RECRUITING ·Phase: PHASE2
-
Disease-Modifying Treatments for Myasthenia Gravis
NCT03490539 ·Status: COMPLETED
-
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
NCT02414490 ·Status: COMPLETED
-
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
NCT00666263 ·Status: COMPLETED ·Phase: PHASE3